{"abstract":"The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to MiRecule, Inc., located in Rockville, Maryland, to practice the inventions embodied in the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/08/07/2017-16524.html","cfr_references":[],"citation":"82 FR 36809","comment_url":null,"comments_close_on":"2017-08-22","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NHLBI Office of Technology Transfer and Development August 22, 2017 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2017-16524","effective_on":null,"end_page":36810,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/08/07/2017-16524.xml","html_url":"https://www.federalregister.gov/documents/2017/08/07/2017-16524/prospective-grant-of-exclusive-patent-license-microrna-therapeutics-for-treating-squamous-cell","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-16524?publication_date=2017-08-07","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-08-07/2017-16524/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":199,"last_updated":"2026-06-24 00:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-08-07/pdf/2017-16524.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-16524.pdf?1501850744","publication_date":"2017-08-07","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/08/07/2017-16524.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T06:50:44Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":36809,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: MicroRNA Therapeutics for Treating Squamous Cell Carcinomas","toc_doc":"MicroRNA Therapeutics For Treating Squamous Cell Carcinomas","toc_subject":"Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":82}